Using epidemiologic methods to study the uses, benefits, and harms of medical interventions to inform clinical decision-making and improve population health
Latest News
The Lund Research Group is proud to have joined the Tomma’s Tar Heelers team in fundraising and participating in the Lung Cancer Initiative 18th annual Triangle LUNGe Forward 5K Run, Walk and Celebration. LUNGe Forward events provide a day of hope, … Read more
In observance of March 14th (3/14), Pi (π) Day, members of the Lund Research Group competed in a pie-bake-off at the 2nd Annual Pharmacoepidemiology Program Causal Pi(e) Day Celebration! The gathering, organized by the Pharmacoepidemiology Program’s very own Dr. Mollie Wood, showcased the talents of … Read more
Did you know that more than 8,000 people are diagnosed with lung cancer each year in North Carolina? Five-year survival for lung cancer has been improving, and is now 21%, thanks to research, screening and earlier diagnosis, and better treatment … Read more
The American Cancer Society has awarded a five-year, $1.2 million Team Science grant to a group of UNC-Chapel Hill researchers who will develop new methods to measure and map cancer screening across North Carolina. TOP ROW, FROM LEFT: DRS. KATHERINE … Read more